Foresee Competitors

Stocks . Taiwan . 
Stock . Foresee Pharmaceuticals Co
6576 Stock  TWD 77.70  0.10  0.13%   
Foresee Pharmaceuticals competes with Fortune Information, Vanguard International, Sinopower Semiconductor, Hi Lai, and Dimerco Data; as well as few others. The company operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. Analyzing Foresee Pharmaceuticals competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Foresee Pharmaceuticals to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Foresee Pharmaceuticals Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Foresee Pharmaceuticals competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
76.3977.7079.01
Details
Intrinsic
Valuation
LowRealHigh
63.9465.2585.47
Details

Foresee Pharmaceuticals Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Foresee Pharmaceuticals and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Foresee and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Foresee Pharmaceuticals does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
6770
+ 0.91
3006
3006
+ 0.84
6435
1268
+ 0.77
6435
6770
+ 0.74
6435
5403
+ 0.72
2468
5403
+ 0.66
5347
  
High negative correlations   
6770
- 0.46
2468
3006
- 0.29
2468
6435
- 0.26
2468
1268
- 0.18
2468

Risk-Adjusted Indicators

There is a big difference between Foresee Stock performing well and Foresee Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Foresee Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Foresee Pharmaceuticals Competitive Analysis

The better you understand Foresee Pharmaceuticals competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Foresee Pharmaceuticals' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Foresee Pharmaceuticals' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
6576 2468 5347 6435 1268 5403 3006 6770
 0.13 
 77.70 
Foresee
 1.58 
 28.10 
Fortune
 0.50 
 101.50 
Vanguard
 0.31 
 95.90 
Sinopower
 0.34 
 148.50 
1268
 0.42 
 119.00 
Dimerco
 0.77 
 64.10 
Elite
 0.30 
 16.55 
Powerchip
Market Volatility
(90 Days Market Risk)
Very steady
Not too volatile
Very steady
Very steady
Very steady
Very steady
Very steady
Not too volatile
Market Performance
(90 Days Performance)
Very Weak
OK
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Below Average
Low
Low
Low
Low
Low
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Fairly Valued
Over Valued
Fairly Valued
Fairly Valued
Fairly Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Cautious Hold
Strong Sell
Cautious Hold
Cautious Hold
Hold
Cautious Hold
Current Ratio
18.76 X
2.73 X
1.76 X
N/A
1.33 X
1.28 X
3.30 X
N/A
Net Asset
1.64 B
1.86 B
65.55 B
2.47 B
4.66 B
4.66 B
20.24 B
132.06 B
Profit Margin
(1.57) %
0.03 %
0.30 %
0.17 %
0.05 %
0.11 %
0.16 %
0.32 %
EBITDA
(475.83 M)
72.57 M
18.33 B
560.53 M
475.55 M
588.21 M
6.53 B
26.15 B
Operating Margin
(1.57) %
0.03 %
0.36 %
0.19 %
0.03 %
0.13 %
0.15 %
0.38 %
Current Valuation
10.39 B
2.01 B
117.95 B
3.31 B
7.07 B
4.5 B
15.85 B
96.67 B
Price To Book
10.24 X
1.68 X
3.19 X
2.32 X
3.27 X
2.70 X
1.53 X
1.43 X
Retained Earnings
N/A
362 M
N/A
N/A
N/A
N/A
3.78 B
N/A
Current Asset
N/A
987 M
N/A
N/A
N/A
N/A
7.53 B
N/A
Five Year Return
N/A
3.90 %
4.70 %
N/A
3.67 %
6.59 %
4.63 %
N/A
Beta
1.42
0.55
1.51
1.12
0.57
0.3
1.49
0.95
Number Of Employees
29
19
36
15
11
10
17
10
Shares Outstanding
118.12 M
69.96 M
1.64 B
33.43 M
42.22 M
74.33 M
272.8 M
3.95 B
Cash Flow From Operations
(213.33 M)
185.65 M
21.24 B
403.45 M
423.53 M
579.88 M
8.29 B
24.19 B
Annual Yield
N/A
0.01 %
0.05 %
0.07 %
0.02 %
0.05 %
0.10 %
0.04 %
Total Debt
N/A
19.16 M
4.99 B
N/A
1.53 B
82.42 M
751.67 M
15.76 B
Return On Equity
-0.35
0.0506
0.44
0.42
0.12
0.24
0.27
0.36
Z Score
N/A
63.4
18.0
1.0
2.4
39.6
17.8
4.8
Return On Asset
-0.18
0.0175
0.16
0.18
0.0147
0.0701
0.0952
0.14
Book Value Per Share
9.36 X
16.80 X
26.10 X
44.65 X
41.01 X
25.14 X
45.71 X
23.38 X
Current Liabilities
N/A
367 M
N/A
N/A
N/A
N/A
2.18 B
N/A
Total Asset
1.64 B
1.86 B
65.55 B
2.47 B
4.66 B
4.66 B
20.24 B
132.06 B
Debt To Equity
0.01 %
1.60 %
5.10 %
N/A
0.98 %
N/A
10.20 %
N/A
Target Price
110.0
N/A
68.8
N/A
N/A
N/A
65.0
28.85
Last Dividend Paid
N/A
0.4
4.5
7.2
3.0
3.81
8.0
1.91
Shares Owned By Institutions
3.14 %
N/A
44.03 %
0.63 %
N/A
3.03 %
11.57 %
10.12 %
Market Capitalization
12.58 B
2.01 B
153.24 B
3.58 B
6.21 B
5.48 B
21.36 B
132.62 B
Price To Earning
N/A
18.92 X
16.96 X
N/A
13.50 X
13.07 X
15.29 X
N/A
Price To Sales
39.29 X
0.87 X
2.47 X
1.02 X
1.53 X
1.19 X
0.99 X
1.58 X
Net Income
(569.27 M)
44.68 M
11.82 B
437.22 M
75.34 M
404.77 M
4.98 B
16.09 B
Earnings Per Share
(4.53) X
0.84 X
9.84 X
16.32 X
4.84 X
6.12 X
11.04 X
6.60 X
Shares Owned By Insiders
35.40 %
72.52 %
28.63 %
53.77 %
74.10 %
26.16 %
13.93 %
26.69 %
Revenue
226.03 M
2.15 B
43.95 B
3.12 B
2.93 B
4.07 B
23.84 B
65.62 B
Working Capital
N/A
620 M
N/A
N/A
N/A
N/A
5.35 B
N/A
Cash And Equivalents
1.34 B
273.16 M
13.11 B
N/A
1.57 B
236.71 M
2.3 B
N/A
Cash Per Share
11.47 X
3.90 X
8.00 X
N/A
42.25 X
3.18 X
8.43 X
N/A
Gross Profit
175.08 M
231.96 M
19.15 B
789.53 M
1.17 B
1.06 B
8.72 B
27.58 B
Day Typical Price
77.83
28.57
101.5
95.83
148.83
118.83
64.27
16.4
Accumulation Distribution
0.0128
241289.0
89231.69
1165.32
607.09
246.68
9953.28
362684.0
Market Facilitation Index
1.0
N/A
N/A
0.0
0.0
0.0
0.0
N/A
Daily Balance Of Power
(0.10)
(0.28)
0.25
(0.19)
(0.25)
1.0
(0.56)
0.1111
Period Momentum Indicator
(0.10)
(0.45)
0.5
(0.30)
(0.50)
0.5
(0.50)
0.05
Rate Of Daily Change
1.0
0.98
1.0
1.0
1.0
1.0
0.99
1.0
Day Median Price
77.9
28.8
101.5
95.8
149.0
118.75
64.35
16.33
Price Action Indicator
(0.25)
(0.92)
0.25
(0.05)
(0.75)
0.5
(0.50)
0.25
Coefficient Of Variation
(1,818)
888.67
(13,817)
(2,373)
(2,570)
5979.23
(756.58)
(600.76)
Mean Deviation
0.8557
1.86
1.28
1.14
0.3352
0.6987
1.34
1.62
Jensen Alpha
(0.07)
0.3218
(0.03)
(0.08)
(0.03)
0.0089
(0.23)
(0.37)
Total Risk Alpha
(0.12)
0.2301
(0.08)
(0.12)
(0.04)
(0.02)
(0.27)
(0.42)
Sortino Ratio
N/A
0.1679
N/A
N/A
N/A
(0.01)
N/A
N/A
Downside Variance
N/A
2.92
N/A
N/A
N/A
1.8
N/A
N/A
Standard Deviation
1.3
2.84
1.93
1.57
0.4906
1.16
1.65
2.1
Kurtosis
2.37
4.72
4.46
1.16
2.27
6.17
(0.39)
0.4308
Potential Upside
2.85
7.48
2.74
2.72
0.9772
1.38
2.1
3.83
Treynor Ratio
0.2686
(0.54)
(0.11)
1.28
(0.51)
0.44
(0.77)
(1.13)
Maximum Drawdown
7.48
13.9
8.59
8.43
2.96
8.27
7.31
9.71
Variance
1.69
8.04
3.74
2.48
0.2406
1.34
2.72
4.4
Market Risk Adjusted Performance
0.2786
(0.53)
(0.10)
1.29
(0.50)
0.45
(0.76)
(1.12)
Risk Adjusted Performance
(0.04)
0.0969
1.0E-4
(0.03)
(0.04)
0.0164
(0.10)
(0.13)
Skewness
0.9026
2.01
1.1
0.5872
0.7133
0.7749
0.1161
0.329
Semi Deviation
N/A
1.42
N/A
N/A
N/A
0.9618
N/A
N/A
Information Ratio
(0.08)
0.1012
(0.02)
(0.06)
(0.10)
(0.01)
(0.15)
(0.18)
Value At Risk
(2.07)
(2.61)
(2.28)
(2.26)
(0.66)
(1.78)
(2.70)
(3.22)
Expected Short fall
N/A
(2.87)
N/A
N/A
N/A
(0.94)
N/A
N/A
Downside Deviation
N/A
1.71
N/A
N/A
N/A
1.34
N/A
N/A
Semi Variance
N/A
2.02
N/A
N/A
N/A
0.925
N/A
N/A

Foresee Pharmaceuticals Competition Performance Charts

Five steps to successful analysis of Foresee Pharmaceuticals Competition

Foresee Pharmaceuticals' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Foresee Pharmaceuticals in relation to its competition. Foresee Pharmaceuticals' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Foresee Pharmaceuticals in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Foresee Pharmaceuticals' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Foresee Pharmaceuticals, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Foresee Pharmaceuticals position

In addition to having Foresee Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Banking Thematic Idea Now

Banking
Banking Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Banking theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banking Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Foresee Stock Analysis

When running Foresee Pharmaceuticals' price analysis, check to measure Foresee Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foresee Pharmaceuticals is operating at the current time. Most of Foresee Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Foresee Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foresee Pharmaceuticals' price. Additionally, you may evaluate how the addition of Foresee Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY